These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 3105322)

  • 21. Clusterin expression in malignant lymphomas: a survey of 266 cases.
    Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
    Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Tac antigen in B cell lymphomas.
    Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
    Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
    Knowles DM; Halper JP; Jakobiec FA
    Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.
    Knowles DM
    Am J Pathol; 1989 Apr; 134(4):761-85. PubMed ID: 2495724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.
    Vyth-Dreese FA; Dellemijn TA; Hekman A; Melief CJ
    Leukemia; 1988 Apr; 2(4):231-5. PubMed ID: 3129622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and prognostic value of immunohistological bone marrow examination: results in 212 patients with lymphoproliferative disorders.
    Thaler J; Denz H; Gattringer C; Glassl H; Lechleitner M; Dietze O; Huber H
    Blut; 1987 Apr; 54(4):213-22. PubMed ID: 3103722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.
    Stein H; Mason DY; Gerdes J; O'Connor N; Wainscoat J; Pallesen G; Gatter K; Falini B; Delsol G; Lemke H
    Blood; 1985 Oct; 66(4):848-58. PubMed ID: 3876124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
    Weisenburger DD
    Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The identification and classification of non-hodgkin's lymphoma: A review.
    Wright DH
    Diagn Histopathol; 1982; 5(2):73-111. PubMed ID: 7047122
    [No Abstract]   [Full Text] [Related]  

  • 35. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
    Schwarze EW
    Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma.
    Picker LJ; Weiss LM; Medeiros LJ; Wood GS; Warnke RA
    Am J Pathol; 1987 Jul; 128(1):181-201. PubMed ID: 3111266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-2 receptor is functionally linked with in vitro activation of B cells isolated from non-Hodgkin's lymphomas.
    Garraud O; LeGrand E; Eghbali H; Hoerni-Simon G; Hoerni B; Guillemain B
    Diagn Clin Immunol; 1988; 5(6):417-20. PubMed ID: 3265363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and signal transduction of T-cell antigen receptor (TCR)/CD3 complexes on fresh or in vitro expanded T lymphocytes from patients with Hodgkin's and non-Hodgkin's lymphomas.
    Rubin B; Martin EP; Arnaud J; Delsol G; Plesner T; Ratsimbazafy A; Llobera R; Holm B; Mariame B
    Scand J Immunol; 1997 Jun; 45(6):715-25. PubMed ID: 9201313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.